Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases. Issue 6 (21st August 2021)

• Record Type: Journal Article
• Authors: Javaid, Aamir; Shahab, Omer; Adorno, William; Fernandes, Philip; May, Eve; Syed, Sana
• Is Part Of: Inflammatory bowel diseases. Volume 28:Issue 6(2022)
• Page Start: 819
• Page End: 829
• Publication Date: 2021-08-21
• Subjects: machine learning -- artificial intelligence -- predictive modeling -- inflammatory bowel diseases; Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1093/ibd/izab187
• Languages: English
• ISSNs: 1078-0998

Abstract

Abstract: There is a rising interest in use of big data approaches to personalize treatment of inflammatory bowel diseases (IBDs) and to predict and prevent outcomes such as disease flares and therapeutic nonresponse. Machine learning (ML) provides an avenue to identify and quantify features across vast quantities of data to produce novel insights in disease management. In this review, we cover current approaches in ML-driven predictive outcomes modeling for IBD and relate how advances in other fields of medicine may be applied to improve future IBD predictive models. Numerous studies have incorporated clinical, laboratory, or omics data to predict significant outcomes in IBD, including hospitalizations, outpatient corticosteroid use, biologic response, and refractory disease after colectomy, among others, with considerable health care dollars saved as a result. Encouraging results in other fields of medicine support efforts to use ML image analysis—including analysis of histopathology, endoscopy, and radiology—to further advance outcome predictions in IBD. Though obstacles to clinical implementation include technical barriers, bias within data sets, and incongruence between limited data sets preventing model validation in larger cohorts, ML-predictive analytics have the potential to transform the clinical management of IBD. Future directions include the development of models that synthesize all aforementioned approaches to produce more robust predictive metrics.